MDWD Straddle Strategy

MDWD (MediWound Ltd.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

MDWD (MediWound Ltd.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $166.5M, a beta of 0.14 versus the broader market, a 52-week range of 11.8-19.7, average daily share volume of 103K, a public-listing history dating back to 2014, approximately 121 full-time employees. These structural characteristics shape how MDWD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.14 indicates MDWD has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a straddle on MDWD?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

MDWD snapshot

As of November 13, 2026, spot at $12.84. The straddle on MDWD below is built from the November 13, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this straddle structure on MDWD specifically: IV rank is unavailable in the current snapshot, so regime-based timing for MDWD is inferred from ATM IV alone. The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MDWD expiries trade a higher absolute premium for lower per-day decay. Position sizing on MDWD should anchor to the underlying notional of $12.84 per share and to the trader's directional view on MDWD stock.

MDWD straddle setup

The MDWD straddle below is built from the November 13, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MDWD at $12.84 on that close, the first option leg uses a $13.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MDWD chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MDWD shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$13.00$1.43
Buy 1Put$13.00$1.45

MDWD straddle risk and reward

Net Premium / Debit
-$288.00
Max Profit (per contract)
Unbounded
Max Loss (per contract)
-$284.15
Breakeven(s)
$10.12, $15.88
Risk / Reward Ratio
Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

MDWD straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on MDWD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

MDWD straddle profit and loss curve at expiration with breakevens and current spot markedMDWD straddle payoff at expiration-$200$0$200$400$600$800$1000$5$10$15$20$25Underlying Price ($)P&L at Expiration ($)BE $10.12BE $15.88Spot $12.84
P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.
Underlying Price% From SpotP&L at Expiration
$0.01-99.9%+$1,011.00
$2.85-77.8%+$727.21
$5.69-55.7%+$443.42
$8.52-33.6%+$159.63
$11.36-11.5%-$124.16
$14.20+10.6%-$168.06
$17.04+32.7%+$115.73
$19.88+54.8%+$399.52
$22.71+76.9%+$683.31
$25.55+99.0%+$967.10

When traders use straddle on MDWD

Straddles on MDWD are pure-volatility plays that profit from large moves in either direction; traders typically buy MDWD straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

MDWD thesis for this straddle

A MDWD long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. As a Healthcare name, MDWD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MDWD-specific events.

MDWD straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MDWD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MDWD alongside the broader basket even when MDWD-specific fundamentals are unchanged. Always rebuild the position from current MDWD chain quotes before placing a trade.

Frequently asked questions

What is a straddle on MDWD?
A straddle on MDWD is the straddle strategy applied to MDWD (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With MDWD stock at $12.84 on the November 13, 2026 close, the strikes shown on this page are snapped to the nearest listed MDWD chain strike and the premiums come straight from that session's bid/ask midpoint.
How are MDWD straddle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the MDWD straddle priced from the November 13, 2026 end-of-day chain at a 30-day expiry (ATM IV the current ATM IV), the computed maximum profit is unbounded per contract and the computed maximum loss is -$284.15 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a MDWD straddle?
The breakeven for the MDWD straddle priced on this page is roughly $10.12 and $15.88 at expiration, derived from the November 13, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk.
When should you consider a straddle on MDWD?
Straddles on MDWD are pure-volatility plays that profit from large moves in either direction; traders typically buy MDWD straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current MDWD implied volatility affect this straddle?
Current MDWD ATM IV is the current ATM IV; IV rank context is unavailable in the current snapshot.

Related MDWD analysis